))
Talking the Cure: Discussing COVID-19’s impact on FDA’s inspection program and next steps after the pandemic
Manage episode 290829676 series 2916794
Conteúdo fornecido por Hogan Lovells. Todo o conteúdo do podcast, incluindo episódios, gráficos e descrições de podcast, é carregado e fornecido diretamente por Hogan Lovells ou por seu parceiro de plataforma de podcast. Se você acredita que alguém está usando seu trabalho protegido por direitos autorais sem sua permissão, siga o processo descrito aqui https://pt.player.fm/legal.
In this episode, Phil Katz and Jim Johnson continue their conversation about the impact of COVID-19 on FDA’s drug inspection program and the steps companies should take now and in preparation for when the pandemic is coming to an end. For all updates around COVID-19, visit our COVID-19 hub. You can find additional thought leadership and information regarding Medical Devices and Technology Regulatory on HL Engage. If you are interested in more information all around Life Sciences and Health Care, follow us on LinkedIn and Twitter.
…
continue reading
52 episódios
Compartilhar
